Suppr超能文献

源自非肥胖糖尿病(NOD)小鼠的针对谷氨酸脱羧酶65 kDa异构体的单克隆抗体。

Monoclonal antibodies specific to the glutamic acid decarboxylase 65 kDa isoform derived from a non-obese diabetic (NOD) mouse.

作者信息

Ziegler B, Augstein P, Lühder F, Northemann W, Hamann J, Schlosser M, Klöting I, Michaelis D, Ziegler M

机构信息

Institute of Diabetes Gerhardt Katsch Karlsburg, University of Greifswald, Germany.

出版信息

Diabetes Res. 1994;25(2):47-64.

PMID:7544254
Abstract

Two monoclonal antibodies specifically recognizing the 65 kDa isoform of the enzyme glutamic acid decarboxylase (GAD) were generated by fusion of spleen cells of a non-obese diabetic (NOD) mouse which had received a single intraperitoneal injection of 0.2 ml complete Freund's adjuvant followed three days later by one administration of a subdiabetogenic dose of streptozotocin (80 mg/kg body weight) three days before the fusion experiment was performed. Both monoclonals belong to the IgG1 isotype and were screened with an enzyme-linked immunosorbent assay using rat brain extract as a natural source of GAD and additionally with a capture assay by means of immunoglobulins of a patient with Stiff-man syndrome. The specific binding to the 65 kDa isoform of the enzyme was detected by a radioligand and an enzyme-linked immunosorbent assay using recombinant human glutamic acid decarboxylase specific for both the 67 and 65 kDa isoforms. Both monoclonal antibodies recognize the same antigenic epitope, which is located in the N-terminal region of the first 17 amino acids detected by fragments of human pancreatic 65 kDa GAD. Three out of 30 sera from Type 1 diabetic patients specifically displaced the binding of the monoclonals from 125I-labelled GAD65 measured by radio-immunoassay. A striking binding of both monoclonals M61/8F9 and M61/7E11 to the islets of cryosections of human, monkey, pig and rat pancreas but not to mouse pancreas was detectable. The antibodies failed to bind on the cell surface of viable rat islet cells. It is concluded that also in the diabetes-prone NOD mice GAD65 autoantibodies occur although GAD65 was not detectable in the mouse islets.

摘要

通过将一只非肥胖糖尿病(NOD)小鼠的脾细胞进行融合,产生了两种特异性识别谷氨酸脱羧酶(GAD)65 kDa同工型的单克隆抗体。该NOD小鼠腹腔内单次注射0.2 ml完全弗氏佐剂,三天后在融合实验进行前三天给予一次亚致糖尿病剂量的链脲佐菌素(80 mg/kg体重)。两种单克隆抗体均属于IgG1同种型,使用大鼠脑提取物作为GAD的天然来源,通过酶联免疫吸附测定法进行筛选,此外还通过僵人综合征患者的免疫球蛋白进行捕获测定。使用对67 kDa和65 kDa同工型均特异的重组人谷氨酸脱羧酶,通过放射性配体和酶联免疫吸附测定法检测与该酶65 kDa同工型的特异性结合。两种单克隆抗体识别相同的抗原表位,该表位位于人胰腺65 kDa GAD片段检测到的前17个氨基酸的N端区域。1型糖尿病患者的30份血清中有3份通过放射免疫测定法特异性地取代了单克隆抗体与125I标记的GAD65的结合。可检测到单克隆抗体M61/8F9和M61/7E11与人、猴、猪和大鼠胰腺冰冻切片的胰岛有显著结合,但与小鼠胰腺无结合。这些抗体未能与活的大鼠胰岛细胞的细胞表面结合。得出的结论是,尽管在小鼠胰岛中未检测到GAD65,但在易患糖尿病的NOD小鼠中也会出现GAD65自身抗体。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验